Microbot Medical (MBOT) Research & Development (2010 - 2026)

Microbot Medical's Research & Development history runs 17 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• Quarterly Research & Development fell 11.38% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.1 million (down 11.6% YoY) and the FY2025 annual result came in at $6.3 million, down 5.23% from the prior year.
• Research & Development was $1.3 million for Q1 2026 at Microbot Medical, down from $1.5 million in the prior quarter.
• Across five years, Research & Development topped out at $2.2 million in Q2 2022 and bottomed at $1.1 million in Q4 2023.
• A 5-year average of $1.6 million and a median of $1.6 million in 2023 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2024 — Research & Development soared 75.58% — and 2025, when it slumped 43.16%.
• Microbot Medical's Research & Development stood at $1.9 million in 2022, then tumbled by 40.02% to $1.1 million in 2023, then surged by 75.58% to $2.0 million in 2024, then dropped by 22.28% to $1.5 million in 2025, then retreated by 16.15% to $1.3 million in 2026.
• Business Quant data shows MBOT's Research & Development at $1.3 million in Q1 2026, $1.5 million in Q4 2025, and $1.2 million in Q3 2025.